Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1

• Published in: Frontiers in immunology Vol. 12; p. 648815
• Main Authors: Yang, Jing, Perez, Edith A., Hou, Changchun, Zhang, Pin, Van Scoyk, Michelle, Winn, Robert A., Rong, Lijun, Liu, Jing
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 07.07.2021
• Subjects: chromatin immunoprecipitation; COPD; COVID-19; Immunology; SARS-CoV-2 receptor ACE2; transcriptional regulation
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2021.648815

Multiple lines of evidence have demonstrated that cigarette smoke or Chronic Obstructive Pulmonary Disease upregulates angiotensin-converting enzyme 2, the cellular receptor for the entry of the severe acute respiratory syndrome coronavirus 2, which predisposes individuals to develop severe Coronavirus disease 2019. The reason for this observation is unknown. We recently reported that the loss of function of Miz1 in the lung epithelium in mice leads to a spontaneous COPD-like phenotype, associated with upregulation of angiotensin-converting enzyme 2. We also reported that cigarette smoke exposure downregulates Miz1 in lung epithelial cells and in mice, and Miz1 is also downregulated in the lungs of COPD patients. Here, we provide further evidence that Miz1 directly binds to and represses the promoter of angiotensin-converting enzyme 2 in mouse and human lung epithelial cells. Our data provide a potential molecular mechanism for the upregulation of angiotensin-converting enzyme 2 observed in smokers and COPD patients, with implication in severe Coronavirus disease 2019.